| Basics |
Cellectis S.A.
Cellectis SA is a gene-editing company, employing its core proprietary technologies to develop products in the emerging field of immuno-oncology. Its two segment includes Therapeutics and Plants.
|
| IPO Date: |
March 25, 2015 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$151.44M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.37 | 2.50%
|
| Avg Daily Range (30 D): |
$0.04 | 2.62%
|
| Avg Daily Range (90 D): |
$0.05 | 3.12%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.2M |
| Avg Daily Volume (30 D): |
.07M |
| Avg Daily Volume (90 D): |
.25M |
| Trade Size |
| Avg Trade Size (Sh.): |
134 |
| Avg Trade Size (Sh.) (30 D): |
252 |
| Avg Trade Size (Sh.) (90 D): |
213 |
| Institutional Trades |
| Total Inst.Trades: |
218 |
| Avg Inst. Trade: |
$1.71M |
| Avg Inst. Trade (30 D): |
$.99M |
| Avg Inst. Trade (90 D): |
$.99M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.76M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
78.34K |
|
|
|
|
|
